Identification of novel immunohistochemical tumor markers for primary hepatocellular carcinoma; clathrin heavy chain and formiminotransferase cyclodeaminase†
Masanori Seimiya(Chiba University), Fumio Nomura(Chiba Prefectural Institute of Public Health), Shigetsugu Takano(University of Pennsylvania), Kazuyuki Matsushita, Takeshi Tomonaga(National Institute of Biomedical Innovation, Health and Nutrition), Masaru Miyazaki(NTT (Japan)), Masayuki Nakano(Nihon University), Yoshio Kodera(Kitasato University), Tadakazu Maeda(Kitasato University), Akira Togawa(National Heart Lung and Blood Institute), Masamichi Ohishi(Kitasato University), Masahiko Sunaga(Chiba University), Masakazu Yamamoto(Tokyo Women's Medical University), Masayuki Otsuka, Hideyuki Yoshitomi(Dokkyo Medical University Saitama Medical Center)
Cited by 84
Related Papers
Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan
|British Journal of Cancer|2010|749
Randomized clinical trial of adjuvant gemcitabine chemotherapy <i>versus</i> observation in resected bile duct cancer
|British journal of surgery|2018|401
Imaging Study of Early Hepatocellular Carcinoma: Usefulness of Gadoxetic Acid–enhanced MR Imaging
|Radiology|2011|354
cHCC‐CCA
|Hepatology|2018|333